Lynx1 Capital Management LP

CIK 1910456
Transactions on file
21
Open-market buys
21
Win rate (buys)
60%
20 scored
Avg % since filing (buys)
+41.8%

Tickers traded

Recent activity

FiledTxn dateIssuerRolesCodeSharesValue% since FilingFiling
2026-06-292026-06-25PASG
Passage BIO, Inc.
10%
Buy50,055$206.1K+12.2%open →
2025-05-212025-05-19TCRX
TScan Therapeutics, Inc.
10%
Buy1,388,794$1.67M-23.3%open →
2025-05-212025-05-20TCRX
TScan Therapeutics, Inc.
10%
Buy1,200,000$1.44M-23.3%open →
2025-12-232025-12-23TCRX
TScan Therapeutics, Inc.
10%
Buy6,232$5.6K+2.3%open →
2025-12-232025-12-22TCRX
TScan Therapeutics, Inc.
10%
Buy75,500$68.0K+2.2%open →
2025-12-232025-12-19TCRX
TScan Therapeutics, Inc.
10%
Buy80,069$72.0K+2.3%open →
2025-10-302025-10-28CGEM
Cullinan Therapeutics, Inc.
10%
Buy165,667$1.39M+104.9%open →
2025-10-232025-10-21NEUP
Neuphoria Therapeutics Inc.
10%
Buy639,110$3.28Mopen →
2025-10-212025-10-17CGEM
Cullinan Therapeutics, Inc.
10%
Buy32,217$252.6K+119.5%open →
2025-10-212025-10-16CGEM
Cullinan Therapeutics, Inc.
10%
Buy150,000$1.33M+94.4%open →
2025-10-212025-10-15CGEM
Cullinan Therapeutics, Inc.
10%
Buy51,500$409.0K+116.7%open →
2025-10-212025-10-14CGEM
Cullinan Therapeutics, Inc.
10%
Buy15,032$114.0K+126.8%open →
2025-10-102025-10-10CGEM
Cullinan Therapeutics, Inc.
10%
Buy277,298$2.04M+133.8%open →
2025-10-102025-10-09CGEM
Cullinan Therapeutics, Inc.
10%
Buy626,043$4.19M+157.0%open →
2025-10-102025-10-08CGEM
Cullinan Therapeutics, Inc.
10%
Buy556,300$3.59M+166.4%open →
2025-07-242025-07-23PASG
Passage BIO, Inc.
10%
Buy49,302$283.0K-19.5%open →
2025-07-242025-07-22PASG
Passage BIO, Inc.
10%
Buy13,123$71.4K-15.1%open →
2025-07-242025-07-24PASG
Passage BIO, Inc.
10%
Buy66,423$379.3K-19.1%open →
2025-09-152025-09-12PASG
Passage BIO, Inc.
10%
Buy19,783$138.3K-33.9%open →
2025-09-152025-09-11PASG
Passage BIO, Inc.
10%
Buy325$2.3K-33.6%open →
2025-09-152025-09-15PASG
Passage BIO, Inc.
10%
Buy11,900$83.2K-33.9%open →